about
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up studyBacterial-viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospectsHealth and social impacts of COPD and the problem of under-diagnosisHsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary diseaseGeneral characteristics and risk factors of cardiovascular disease among interstate bus driversHsp10 nuclear localization and changes in lung cells response to cigarette smoke suggest novel roles for this chaperonin.Convergent sets of data from in vivo and in vitro methods point to an active role of Hsp60 in chronic obstructive pulmonary disease pathogenesis.Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD.Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis.Italian registry of patients with alpha-1 antitrypsin deficiency: general data and quality of life evaluation.Telemedicine: a new frontier for effective healthcare services.Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults.Development of a Barthel Index based on dyspnea for patients with respiratory diseases.Comparing airways clearance techniques in chronic obstructive pulmonary disease and bronchiectasis: positive expiratory pressure or temporary positive expiratory pressure? A retrospective studyPhospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium.General practitioners and rare lung diseases: a task force for the development of rare lung diseases educational material.Patients' characterization, hospital course and clinical outcomes in five Italian respiratory intensive care units.The T-cell antigen receptor: methods of study and relevance in the pathogenesis of pulmonary disorders.Requirement for different presenting cells and for different processing mechanisms by human CD4 T helper clones specific for M. tuberculosis antigens.Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity.The interstitial lung disease associated with rheumatoid arthritis: evidence for imbalance of helper T-lymphocyte subpopulations at sites of disease activity.Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple?MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients.[Sleep apnea, CPAP therapy and work activity].T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.Efficacy of temporary positive expiratory pressure (TPEP) in patients with lung diseases and chronic mucus hypersecretion. The UNIKO® project: a multicentre randomized controlled trial.TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD.Gait abnormalities of COPD are not directly related to respiratory function.HSP60 activity on human bronchial epithelial cells.Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression.High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD.Expression of vascular remodelling markers in relation to bradykinin receptors in asthma and COPD.Primary human mesothelioma cells express class II MHC, ICAM-1 and B7-2 and can present recall antigens to autologous blood lymphocytes.Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): The Maugeri Study.Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs.Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis.Tele-assistance in chronic respiratory failure patients: a randomised clinical trialA pilot study of nurse-led, home monitoring for patients with chronic respiratory failure and with mechanical ventilation assistanceAging and Induced-Sputum Cells
P50
Q24813038-83CD7B24-F6EA-4ABA-88FF-8E8E7456A4C4Q26752882-3E455759-C32E-404F-A737-1348A517B1A6Q26864108-6E89C5C7-DEC3-49C4-9D51-B211A6B718DDQ28269033-92276301-AC8F-425A-9423-EA788EBE66BCQ28385439-1D6A98E0-E160-48F7-9901-3F3CA56DCEE9Q30596990-07C21F0D-3A8D-448E-8B44-DDDE8D0F794AQ34091346-AFC8EB58-D602-444B-B1FE-BB33E7B6A38DQ34447539-5D114700-F721-4EF3-8415-AE86935CC6B2Q34745513-227186E8-4246-4FD5-821A-7D6B5D95F7DEQ35621441-15AB20B6-7CD6-437B-A212-CE17D89271CEQ36135062-2AD39C3F-1D74-47C6-B0E4-EA5BCF79DA12Q36955883-8D09CC66-6D5C-4850-BB1D-BF699A8F15C2Q37003158-1F7E3C05-8744-4DEB-9CDD-01DEB793998CQ38820367-60AEBF7E-CC9B-4AD8-981B-2E51C69B2C2EQ38897435-35153AB1-07F7-4E40-BCF7-95D6982BCDB2Q39140026-38836E2A-7640-445C-AF4D-106EBEB86446Q39943897-901260E2-06F1-4335-9A3A-C6DF10CEFC73Q40757642-31373DC8-2971-414B-BF0C-C5DB650D7E4FQ41035975-E811587A-4750-400A-B076-8FC59D3A2C96Q41249113-7833A032-361B-4697-AF23-4F13B425B074Q41356546-7E892B50-86AF-4615-89F6-9A2CB886959DQ42018799-CCFBEDDF-E43B-4D7D-9D4F-E375D513E84BQ43504825-57CA4D64-6C91-4BD1-A894-84076F7C5948Q44146146-1E2AA881-4324-4232-82CF-0ABD51C6C4D6Q45928617-7BDC44F9-D8C3-4B9B-A04D-B1C06DD16768Q46644857-5B3075BF-7520-4D09-A0C9-8580FBD1AD20Q47242451-D1611F3F-14E1-4203-9D74-74A75621793DQ47630776-5E046E24-E1B0-4C21-9ADB-3A393EA65711Q47701583-C8D5D42A-2EB8-4BB4-8E38-61837B39B5D3Q48110451-2FB17C52-7DF4-43D2-BBED-311E5C2952A6Q50789709-EB399958-D40F-4701-A422-BB7D39741E81Q50934543-C1A80B50-6766-4D72-BD4E-00779A67CC44Q52036585-C376D8FA-8A4B-40E6-BEFF-E81073B351BBQ52986003-91FB1DB9-E17D-43CB-AE5B-96FD1E15D2BDQ53178952-01D5471A-CFB5-42CE-B9E2-A02EA027CDD0Q53190778-B245DC15-451B-435A-AA7C-C85B827356AAQ53816896-2ACE2304-17C6-4DD7-AC91-E8B46B6C624FQ61885544-CB77A1A8-5BF7-4415-9094-16B089C7BEC9Q61885579-970F673F-18E4-485C-8F9F-A5562889D4D9Q61885586-4F796A85-B906-44A4-B695-2625F9C293C2
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bruno Balbi
@ast
Bruno Balbi
@en
Bruno Balbi
@es
Bruno Balbi
@nl
type
label
Bruno Balbi
@ast
Bruno Balbi
@en
Bruno Balbi
@es
Bruno Balbi
@nl
prefLabel
Bruno Balbi
@ast
Bruno Balbi
@en
Bruno Balbi
@es
Bruno Balbi
@nl
P106
P1153
7003280215
P21
P31
P496
0000-0002-4439-1424